OTCMKTS:BICX - Biocorrx Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Biocorrx Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.91 +0.01 (+0.34 %) (As of 01/17/2020 03:19 PM ET) Add Compare Today's Range$2.90Now: $2.91▼$2.9550-Day Range$2.57MA: $2.90▼$3.2952-Week Range$2.46Now: $2.91▼$13.94Volume990 shsAverage Volume911 shsMarket Capitalization$15.46 millionP/E RatioN/ADividend YieldN/ABeta1.03 ProfileAdvanced ChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Specialty outpatient clinics, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BICX Previous Symbol CUSIPN/A CIK1443863 Webhttp://www.biocorrx.com/ Phone714-462-4880Debt Debt-to-Equity RatioN/A Current Ratio1.66 Quick Ratio1.66Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$380,000.00 Price / Sales40.68 Cash FlowN/A Price / Cash FlowN/A Book Value($2.20) per share Price / Book-1.32Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-6,510,000.00 Net Margins-3,147.58% Return on EquityN/A Return on Assets-263.26%Miscellaneous EmployeesN/A Outstanding Shares5,312,000Market Cap$15.46 million Next Earnings Date4/21/2020 (Estimated) OptionableNot Optionable Receive BICX News and Ratings via Email Sign-up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter. OTC:BICX Rates by TradingView Biocorrx (OTCMKTS:BICX) Frequently Asked Questions What is Biocorrx's stock symbol? Biocorrx trades on the OTCMKTS under the ticker symbol "BICX." How were Biocorrx's earnings last quarter? Biocorrx Inc (OTCMKTS:BICX) released its quarterly earnings results on Thursday, November, 14th. The company reported ($0.33) earnings per share (EPS) for the quarter. The business had revenue of $0.05 million for the quarter. View Biocorrx's Earnings History. When is Biocorrx's next earnings date? Biocorrx is scheduled to release their next quarterly earnings announcement on Tuesday, April 21st 2020. View Earnings Estimates for Biocorrx. Has Biocorrx been receiving favorable news coverage? News stories about BICX stock have been trending positive recently, InfoTrie reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Biocorrx earned a news impact score of 3.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Biocorrx. Who are some of Biocorrx's key competitors? Some companies that are related to Biocorrx include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), IMAC (IMAC) and AAC (AAC). What other stocks do shareholders of Biocorrx own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biocorrx investors own include Mondi (MNDI), Alkermes (ALKS), Cronos Group (CRON), Cytori Therapeutics (CYTX), Editas Medicine (EDIT), ImmunoGen (IMGN), Intel (INTC), Netflix (NFLX), Nektar Therapeutics (NKTR) and SS&C Technologies (SSNC). Who are Biocorrx's key executives? Biocorrx's management team includes the folowing people: Brady James Granier, President Chief Executive Officer & DirectorLourdes Felix, Director, Chief Operating & Financial OfficerKenneth Orbeck, Medical DirectorBalbir S. Brar, Senior Vice President-Drug Development How do I buy shares of Biocorrx? Shares of BICX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Biocorrx's stock price today? One share of BICX stock can currently be purchased for approximately $2.91. How big of a company is Biocorrx? Biocorrx has a market capitalization of $15.46 million and generates $380,000.00 in revenue each year. View Additional Information About Biocorrx. What is Biocorrx's official website? The official website for Biocorrx is http://www.biocorrx.com/. How can I contact Biocorrx? Biocorrx's mailing address is 2390 EAST ORANGEWOOD AVENUE SUITE 575, ANAHEIM CA, 92806. The company can be reached via phone at 714-462-4880 or via email at [email protected] MarketBeat Community Rating for Biocorrx (OTCMKTS BICX)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 69 (Vote Outperform)Underperform Votes: 63 (Vote Underperform)Total Votes: 132MarketBeat's community ratings are surveys of what our community members think about Biocorrx and other stocks. Vote "Outperform" if you believe BICX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BICX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/17/2020 by MarketBeat.com StaffFeatured Article: Monthly Dividend Stocks Can Provide Solid Income
